This Article Abstract Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goji, K. Articles by Matsuo, M. Search for Related Content PubMed PubMed Citation Articles by Goji, K. Articles by Matsuo, M. Related Collections Calcium and Bone Metabolism

Somatic and Germline Mosaicism for a Mutation of the PHEX Gene Can Lead to Genetic Transmission of X-Linked Hypophosphatemic Rickets That Mimics an Autosomal Dominant Trait

Department of Endocrinology and Metabolism (K.G., K.O.), Kobe Children’s Hospital, Kobe 654-0081, Japan; and Division of Public Health (A.H.S., H.N.) and Department of Pediatrics (M.M.), Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

Address all correspondence and requests for reprints to: Katsumi Goji, M.D., Department of Endocrinology and Metabolism, Kobe Children’s Hospital, 1-1-1 Takakuradai, Suma-ku, Kobe 654-0081, Japan. E-mail: gojik{at}gold.ocn.ne.jp.

	Abstract

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Context: Familial hypophosphatemic rickets is usually transmitted as an X-linked dominant disorder (XLH), although autosomal dominant forms have also been observed. Genetic studies of these disorders have identified mutations in PHEX and FGF23 as the causes of X-linked dominant disorder and autosomal dominant forms, respectively.

Objective: The objective of the study was to describe the molecular genetic findings in a family affected by hypophosphatemic rickets with presumed autosomal dominant inheritance.

Patients: We studied a family in which the father and the elder of his two daughters, but not the second daughter, were affected by hypophosphatemic rickets. The pedigree interpretation of the family suggested that genetic transmission of the disorder occurred as an autosomal dominant trait.

Methods and Results: Direct nucleotide sequencing of FGF23 and PHEX revealed that the elder daughter was heterozygous for an R567X mutation in PHEX, rather than FGF23, suggesting that the genetic transmission occurred as an X-linked dominant trait. Unexpectedly, the father was heterozygous for this mutation. Single-nucleotide primer extension and denaturing HPLC analysis of the father using DNA from single hair roots revealed that he was a somatic mosaic for the mutation. Haplotype analysis confirmed that the father transmitted the genotypes for 18 markers on the X chromosome equally to his two daughters. The fact that the father transmitted the mutation to only one of his two daughters indicated that he was a germline mosaic for the mutation.

Conclusions: Somatic and germline mosaicism for an X-linked dominant mutation in PHEX may mimic autosomal dominant inheritance.

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion References

 
FAMILIAL HYPOPHOSPHATEMIC RICKETS is the most common inherited form of rickets and is characterized by growth retardation, defective bone mineralization, hypophosphatemia secondary to renal phosphate wasting, and an inappropriately low serum concentration of 1,25-dihydroxyvitamin D. Hypophosphatemic rickets is usually transmitted as an X-linked dominant disorder (XLH) (1), although autosomal dominant forms (ADHR) have also been observed (2, 3, 4). Genetic studies of these disorders have identified mutations in PHEX and FGF23 as the causes of XLH and ADHR, respectively (5, 6). PHEX is a member of the M13 family of type II cell-surface membrane zinc-dependent proteases, which also includes two endothelin-converting enzymes (ECEs), ECE-1 and -2; neprilysin; and the KELL antigen (7, 8, 9, 10). PHEX protein is predominantly expressed in osteoblasts and odontoblasts but not in the kidney (11, 12). On the basis of the tissue distribution of PHEX and the reported actions of neprilysin, ECE-1, and ECE-2 (7, 8, 13, 14), it has been postulated that PHEX plays a role in the activation or inactivation of peptide factors that have roles in osteoblast differentiation and/or mineralization. In addition, PHEX may also participate in the control of renal phosphate handling and vitamin D metabolism (15). However, endogenous PHEX substrates and products have not yet been identified.

In this paper, we report a family affected by hypophosphatemic rickets. In this family, the father and the elder of his two daughters were affected by hypophosphatemic rickets, whereas the second daughter was not. The pedigree interpretation of the family suggested that genetic transmission of the disorder occurred as an autosomal dominant trait. However, molecular analysis disclosed that the transmission occurred as an X-linked dominant trait and that the affected father was a somatic and germline mosaic for the PHEX gene.

	Subjects and Methods

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Family K (Fig. 1)

The proband (III-1) was a 4-yr-old girl of Japanese origin. She was referred at the age of 19 months with lower extremity bowing. Fasting blood and urine samples revealed normal renal function and no acidosis. Serum calcium was 10.1 mg/dl (2.53 mmol/liter), phosphorus was 2.5 mg/dl (0.81 mmol/liter), alkaline phosphatase was 1875 IU/liter (normal range for children < 900 IU/liter), 1,25-dihydroxyvitamin D₃ was 57.4 pg/dl (137.8 pmol/liter) (normal range for children 20–70 pg/dl), and intact PTH was 44 pg/ml (4.6 pmol/liter) (normal range 10–68 pg/ml). Tubular maximum reabsorption of phosphate per glomerular filtration rate was 2.3 mg/dl (0.92 mmol/liter) (normal range for children 4.36–5.53 mg/dl). She had radiographic evidence of severe rickets. She was treated with 1-hydroxyvitamin D₃ (0.5 µg/day) and sodium phosphate, which led to significant improvement in the radiological signs of rickets after 12 months of therapy.

View larger version (10K): [in this window] [in a new window]   FIG. 1. Pedigree of family K. Black symbols, Patients with hypophosphatemic rickets; arrow, proband.

The parents of the proband gave informed consent for this study. The study was approved by the Institutional Review Board of Kobe Children’s Hospital.

Mutation analysis

Leukocyte DNA was extracted using standard methods. Single hair root DNA was obtained from the proband’s father (II-1) using a DNA extraction kit (QIAamp DNA Micro, QIAGEN, Hilden, Germany). The coding regions and related exon-intron boundaries of FGF23 and PHEX were investigated by automated direct nucleotide sequencing after amplification of the target sequences by PCR. Oligonucleotide PCR primers for each gene were designed using Primer3 software (http://frodo.wi.mit.edu/primer3/primer3_code.html) (16) and are listed in Table 1.

Because the sequence peaks of PHEX obtained from leukocyte DNA from the proband’s father (II-1) indicated that the father, who was expected to be hemizygous, was actually heterozygous for mutant and normal alleles, we performed single-nucleotide primer extension and denaturing HPLC (DHPLC) on DNA extracted from leukocytes and hair roots. After primer extension using Thermo Sequenase (Amersham Bioscience, Piscataway, NJ), the wild-type and mutant alleles were discriminated and quantified by DHPLC (17, 18).

Before the primer extension reaction, 5 µl of a PCR product containing the mutation were treated with 2 µl of ExoSAP-IT (Amersham Bioscience) to remove unincorporated primers and deoxynucleotide triphosphates. Primer extension reactions were carried out in a final volume of 20 µl containing the purified PCR product (50–60 ng), 50 µM of a mixture of 2',3'-dideoxycytidine-5'-triphosphate (ddCTP) and 2',3'-dideoxythymidine-5'-triphosphate (ddTTP), 15 pmol of a primer (5'-CCTTTCTTTTGGGGAACAGAATATCCT-3') located upstream of the mutation site, and 0.5 U Thermo Sequenase in the buffer provided by the manufacturer. The reaction was performed in a thermal cycler with an initial denaturation step of 1 min at 96 C followed by 50 cycles of 96 C for 10 sec, 43 C for 15 sec, and 60 C for 1 min. At the end of the thermal cycling, the reaction was incubated at 96 C for 30 sec and then immediately placed on ice. Separation of the extended primer was performed by DHPLC using an HPLC machine (Transgenomic Wave System; Transgenomic, Omaha, NE) as previously described (17).

Haplotype analysis using polymorphic markers on the X chromosome

Genomic DNA from leukocytes obtained from the proband (III-1), her sister (III-2), her parents (II-1 and II-2), and her paternal grandparents (I-1 and I-2) were analyzed using polymorphic markers located throughout the full length of the X chromosome. PCR amplification was performed with an ABI PRISM linkage mapping set (version 2.5 MD,10 panel 28; Applied Biosystems, Foster City, CA). The PCR products were run on an ABI PRISM 310 automated sequencer and the allele sizes were determined by the GENESCAN software (Applied Biosystems).

	Results

Top Abstract Introduction Subjects and Methods Results Discussion References

 
Mutation analysis

Direct nucleotide sequencing of FGF23 in the leukocyte DNA from the proband did not reveal any putative disease-causing mutations. Subsequent sequencing of PHEX in the leukocyte DNA from the proband identified a heterozygous C-to-T transition at nucleotide 1699 in exon 16, which resulted in an arginine (CGA)-to-stop codon (TGA) substitution at codon 567 (R567X). Unexpectedly, the proband’s father (II-1) was heterozygous for the mutant and wild-type alleles, whereas the proband’s sister (III-2) did not carry the mutation. The proband’s mother (II-2) and paternal grandparents (I-1 and I-2) did not carry the substitution. Because the mutation eliminates an MnlI restriction enzyme recognition site and creates a StyI site, the heterozygous states of the proband and her father were confirmed by restriction enzyme analysis (Fig. 2).

View larger version (20K): [in this window] [in a new window]   FIG. 2. Restriction enzyme analysis. PCR products of exon 16 of PHEX were digested with MnlI or StyI and separated on a 2% agarose gel. A, The resultant fragment lengths are shown schematically. B, The restriction enzyme analysis confirmed heterozygous states for the mutant and normal alleles in the proband and her father.

Single-nucleotide primer extension and DHPLC analysis of leukocyte DNA from the proband’s father (II-1) revealed that 40% of the tested DNA had the wild-type genotype, whereas 60% had the mutant form. In the proband (III-1), her sister (III-2), and her grandfather (I-1), the proportions of leukocyte DNA carrying the mutant sequence of PHEX were 56, 0, and 0%, respectively (Fig. 3). The same analysis performed on DNA from eight single hair roots from the proband’s father showed four different ratios of the mutant allele: 6% (two samples), 38% (one sample), 64–73% (four samples), and 94% (one sample) (Fig. 4). These ratios are largely consistent with the hypothesis that each hair root originates from three different progenitor cells. Theoretically single hair roots from a man with a mosaic mutation located on the X chromosome show four different ratios of the mutant allele: 0% (no mutant progenitor cells and three normal progenitor cells), 33% (one mutant progenitor cell and two normal progenitor cells), 67% (two mutant progenitor cells and one normal progenitor cell), and 100% (three mutant progenitor cells and no normal progenitor cells) (Fig. 4) (18, 19, 20).

View larger version (22K): [in this window] [in a new window]   FIG. 3. Single nucleotide primer extension and DHPLC analysis using leukocyte DNA and the corresponding direct sequence electrophoregrams. The proportions of leukocyte DNA carrying the mutant sequence of PHEX in the proband’s grandfather (I-1), the proband’s father (II-1), the proband (III-1), and the proband’s sister (III-2) were 0, 60, 56, and 0%, respectively. Asterisks, Unextended primers; C, wild-type alleles; T, mutant alleles.

View larger version (22K): [in this window] [in a new window]   FIG. 4. A, Representative profiles of single-nucleotide primer extension and DHPLC analysis using DNA from eight single hair roots from the proband’s father (II-1). Four different ratios of the mutant allele were observed: 6, 38, 64, and 94%. Asterisks, Unextended primers; C, wild-type alleles; T, mutant alleles. B, Theoretical models for single hair roots from a man with a mosaic mutation are schematically shown. Single hair roots show four different ratios of the mutant allele: 0% (no mutant progenitor cells and three normal progenitor cells), 33% (one mutant progenitor cell and two normal progenitor cells), 67% (two mutant progenitor cells and one normal progenitor cell), and 100% (three mutant progenitor cells and no normal progenitor cells). Open circles, Normal progenitor cells; closed circles, mutant progenitor cells.

The genotypes for 18 markers on the X chromosome of the proband’s father (II-2) were equally inherited by the proband (III-1) and her sister (III-2). The father inherited the genotypes for these markers on the X chromosome from the proband’s grandmother (I-2) (Fig. 5).

View larger version (60K): [in this window] [in a new window]   FIG. 5. Haplotype analysis. The genotypes for 18 markers on the X chromosome of the proband’s father (II-2) were equally inherited by the proband (III-1) and her sister (III-2). There are several possible chromosomal arrangements of the mother (II-2) and paternal grandmother (I-2). At present, however, the correct arrangement is not known because additional information derived from other family members is not available to us.

	Discussion

Top Abstract Introduction Subjects and Methods Results Discussion References

We used single-nucleotide primer extension and DHPLC analysis to confirm and measure the degree of mosaicism. Single-nucleotide primer extension and DHPLC analysis of leukocyte DNA (mesodermal derivatives) from the proband’s father revealed that 60% of the total leukocyte DNA had the mutant genotype. The same analysis performed on DNA from eight single hair roots from the father demonstrated four different proportions of the mutant allele. According to the theory that every human hair root originates from three progenitor cells, this finding indicated that the mutation was not present in all of the father’s ectodermal cells (18, 19, 20). In other words, single hair root DNA analysis revealed that the proband’s father was a somatic mosaic for this mutation of PHEX. Haplotype analysis revealed that the affected father (II-1) transmitted the genotypes for 18 markers on the X chromosome equally to his daughters (III-1 and III-2), but the second daughter did not inherit the mutation of PHEX located on the X chromosome. The fact that the affected father transmitted the mutation to only one of his two daughters indicated that he was a germline mosaic for the mutation. Therefore, the mutation may have occurred during early embryogenesis before the commitment to germ cells.

At an early stage of development, dramatic methylation changes have been observed. During preimplantation development, gamete-specific patterns of methylation are erased by genome-wide demethylation, tending toward a ground state of absence of methylation in the inner cell mass of the blastocyst. Except for a small number of methylated CpG sites in imprinted genes, the vast majority of methylated CpG sites are unmethylated by the stage of cavitation (16-cell stage) (21, 22). The point mutation (CGA-to-TGA) identified in family K occurred at a CpG site, and this site may have been subject to demethylation during the early steps of embryo development. An aberrant process of demethylation could lead to a mosaic mutation at this CpG site during early embryogenesis.

One interesting issue is why the Phex/PHEX gene mutation produces a dominant phenotype. Hyp mice, the mice homolog of human XLH, and XLH patients are truly dominant conditions with similar degrees of bone and renal defects in hemizygotes, heterozygotes, and homozygotes for the disease allele (23, 24, 25, 26, 27). A number of studies have suggested that the dominant pattern of Hyp/XLH inheritance is due to haploinsufficiency, in which the normal Phex/PHEX protein produced by the wild-type allele in heterozygotes does not reach the threshold level necessary for normal Phex/PHEX function (25, 28, 29). In the proband’s father (II-1), 40% of the leukocyte DNA had the wild-type genotype, whereas 60% had the mutant form. Although the genotype in cartilage, bone, and teeth, in which PHEX is predominantly expressed (30, 31), could not be analyzed in the proband’s father, the normal PHEX protein produced by the wild-type allele in these tissues may not reach the threshold level necessary for normal PHEX function.

In summary, we report here a family affected by hypophosphatemic rickets. The pedigree interpretation of this family suggested that genetic transmission of the disorder occurred as an autosomal dominant trait. However, molecular analysis revealed that the transmission occurred as an X-linked dominant trait and that the affected father was a somatic and germline mosaic for a mutation of PHEX. To date, somatic and germline mosaics have been reported for only a few X-linked and autosomal dominant monogenic disorders, and this is the first report of mosaicism for a mutation of PHEX. Somatic and germline mosaicism for an X-linked dominant mutation in the PHEX gene may mimic autosomal dominant inheritance. Mosaicism has important implications for molecular diagnosis interpretation, clinical evaluation, and genetic counseling.

	Footnotes

 
First Published Online November 22, 2005

Abbreviations: ADHR, Autosomal dominant XLH form; DHPLC, denaturing HPLC; ECE, endothelin-converting enzyme; XLH, X-linked dominant disorder.

Received August 5, 2005.

Accepted November 11, 2005.

	References

Top Abstract Introduction Subjects and Methods Results Discussion References

 

1. Rasmussen H, Tenenhouse HS 1995 Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 3717–3745
2. Bianchine JW, Stambler AA, Harrison HE 1971 Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser 7:287–295[Medline]
3. Stamp TC, Baker LR 1976 Recessive hypophosphataemic rickets, and possible aetiology of the ‘vitamin D-resistant’ syndrome. Arch Dis Child 51:360–365[Abstract/Free Full Text]
4. Econs MJ, McEnery PT 1997 Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82:674–681[Abstract/Free Full Text]
5. HYP Consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet 11:130–136[CrossRef][Medline]
6. ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348[CrossRef][Medline]
7. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M 1994 ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473–485[CrossRef][Medline]
8. Emoto N, Yanagisawa M 1995 Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262–15268[Abstract/Free Full Text]
9. Oefner C, D’Arcy A, Hennig M, Winkler FK, Dale GE 2000 Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. J Mol Biol 296:341–349[CrossRef][Medline]
10. Turner AJ, Brown CD, Carson JA, Barnes K 2000 The neprilysin family in health and disease. Adv Exp Med Biol 477:229–240[Medline]
11. Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C, Ecarot B 1996 cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36:22–28[CrossRef][Medline]
12. Thompson DL, Sabbagh Y, Tenenhouse HS, Roche PC, Drezner MK, Salisbury JL, Grande JP, Poeschla EM, Kumar R 2002 Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res 17:311–320[CrossRef][Medline]
13. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A 1993 Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87–146[Medline]
14. Turner AJ, Tanzawa K 1997 Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11:355–364[Abstract]
15. Tenenhouse HS 1999 X-linked hypophosphataemia: a homologous disorder in humans and mice. Nephrol Dial Transplant 14:333–341[Abstract/Free Full Text]
16. Rozen S, Skaletsky H 2000 Primer 3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ: Humana Press; 365-386
17. Giordano M, Mellai M, Hoogendoorn B, Momigliano-Richiardi P 2001 Determination of SNP allele frequencies in pooled DNAs by primer extension genotyping and denaturing high-performance liquid chromatography. J Biochem Biophys Methods 47:101–110[CrossRef][Medline]
18. Guerrini R, Mei D, Sisodiya S, Sicca F, Harding B, Takahashi Y, Dorn T, Yoshida A, Campistol J, Kramer G, Moro F, Dobyns WB, Parrini E 2004 Germline and mosaic mutations of FLN1 in men with periventricular heterotopia. Neurology 63:51–56[Abstract/Free Full Text]
19. Dancis J, Silvers DN, Balis ME, Cox RP, Schwartz MS 1981 Evidence for the derivation of individual hair roots from three progenitor cells. Hum Genet 58:414–416[Medline]
20. Kato M, Kanai M, Soma O, Takusa Y, Kimura T, Numakura C, Matsuki T, Nakamura S, Hayasaka K 2001 Mutation of the double-cortin gene in male patients with double cortex syndrome: somatic mosaicism detected by hair root analysis. Ann Neurol 50:547–551[CrossRef][Medline]
21. Monk M 1995 Epigenetic programming of differential gene expression in development and evolution. Dev Genet 17:188–197[CrossRef][Medline]
22. Razin A, Shemer R 1995 DNA methylation in early development. Hum Mol Genet 4:1751–1755[Abstract]
23. Qiu ZQ, Tenenhouse HS, Scriver CR 1993 Parental origin of mutant allele does not explain absence of gene dose in X-linked Hyp mice. Genet Res 62:39–43[Medline]
24. Meyer Jr RA, Meyer MH, Gray RW, Bruns ME 1995 Femoral abnormalities and vitamin D metabolism in X-linked hypophosphatemic (Hyp and Gy) mice. J Orthop Res 13:30–40[CrossRef][Medline]
25. Qiu ZQ, Travers R, Rauch F, Glorieux FH, Scriver CR, Tenenhouse HS 2004 Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice. Bone 34:134–139[Medline]
26. Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP 1989 X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine (Baltimore) 68:336–352[Medline]
27. Whyte MP, Schranck FW, Armamento-Villareal R 1996 X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 81:4075–4080[Abstract/Free Full Text]
28. Wang L, Du L, Ecarot B 1999 Evidence for Phex haploinsufficiency in murine X-linked hypophosphatemia. Mamm Genome 10:385–389[CrossRef][Medline]
29. Sabbagh Y, Boileau G, Campos M, Carmona AK, Tenenhouse HS 2003 Structure and function of disease-causing missense mutations in the PHEX gene. J Clin Endocrinol Metab 88:2213–2222[Abstract/Free Full Text]
30. Guo R, Quarles LD 1997 Cloning and sequencing of human PEX from a bone cDNA library: evidence for its developmental stage-specific regulation in osteoblasts. J Bone Miner Res 12:1009–1017[CrossRef][Medline]
31. Lipman ML, Panda D, Bennett HP, Henderson JE, Shane E, Shen Y, Goltzman D, Karaplis AC 1998 Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity. J Biol Chem 273:13729–13737[Abstract/Free Full Text]

This article has been cited by other articles:

				J. Kim, K. H. Yang, J. S. Nam, J. R. Choi, J. Song, M. Chang, and K.-A Lee A Novel PHEX Mutation in a Korean Patient with Sporadic Hypophosphatemic Rickets Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 182 - 187. [Abstract] [Full Text] [PDF]

				P. Makras, N. A. T. Hamdy, S. G. Kant, and S. E. Papapoulos Normal Growth and Muscle Dysfunction in X-Linked Hypophosphatemic Rickets Associated with a Novel Mutation in the PHEX Gene J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1386 - 1389. [Abstract] [Full Text] [PDF]

				I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, S. Wolczynski, and M. Gorska Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 1824 - 1829. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goji, K. Articles by Matsuo, M. Search for Related Content PubMed PubMed Citation Articles by Goji, K. Articles by Matsuo, M. Related Collections Calcium and Bone Metabolism